|
Job Title | Location |
Company | Date Posted |
Phoenix West, AZ - Pharmaceutical Sales Representative |
US-AZ | inVentiv Health | 4/21/2018 |
Alcon Glaucoma Sales Specialist - Phoenix AZ |
US-AZ | Novartis | 4/11/2018 |
Alcon Key Account Manager - Phoenix |
US-AZ | Novartis | 4/11/2018 |
Phoenix, AZ-Immunology Specialist |
US-AZ | inVentiv Health | 4/21/2018 |
Phoenix West, AZ - Pharmaceutical Sales Representative |
US-AZ | inVentiv Health | 4/21/2018 |
Phoenix, AZ-Account Manager |
US-AZ | inVentiv Health | 4/21/2018 |
Phoenix, AZ-Specialty Sales Representative |
US-AZ | inVentiv Health | 4/21/2018 |
Per Diem Home Injection Nurse Educator - Phoenix, AZ |
US-AZ | inVentiv Health | 4/21/2018 |
Community Medical Science Liaison - Phoenix, AZ |
US-AZ | inVentiv Health | 4/21/2018 |
Phoenix West, AZ-Pharmaceutical Sales Representative |
US-AZ | inVentiv Health | 4/21/2018 |
Phoenix, AZ-Entry Level Pharmaceutical Sales Representative |
US-AZ | inVentiv Health | 4/21/2018 |
Per Diem Home Injection Nurse Educator- Phoenix, AZ |
US-AZ | inVentiv Health | 4/21/2018 |
Phoenix, AZ-Area Business Specialist |
US-AZ | inVentiv Health | 4/21/2018 |
Senior Scientist, Pharmacometrics |
US-CO | EPM Scientific | 4/21/2018 |
Senior Scientist, Pharmacometrics |
US-CO | Phaidon International | 4/21/2018 |
Director/Executive Director of Clinical Development |
US-AZ | EPM Scientific | 4/21/2018 |
Contract Clinical Trial Manager |
US-AZ | EPM Scientific | 4/21/2018 |
Contract Clinical Trial Manager |
US-AZ | EPM Scientific | 4/21/2018 |
Contract Clinical Trial Manager |
US-AZ | Phaidon International | 4/21/2018 |
Hematology Medical Science Liaison West |
US-AZ | inVentiv Health | 4/21/2018 |
Remote TeleSolutions Nurse Specialist |
US-AZ | inVentiv Health | 4/21/2018 |
Contract Clinical Trial Manager |
US-AZ | Phaidon International | 4/21/2018 |
Project lead Clinical PK/PD |
US-NY | EPM Scientific | 4/21/2018 |
Project lead Clinical PK/PD |
US-NY | Phaidon International | 4/21/2018 |
Global Risk Management Plan Manager |
US-NJ | Novartis | 4/11/2018 |